Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02307916 · ClinicalTrials.gov registry record · Phase 2
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
A Phase 2 study of Tympanic Membrane Perforation, sponsored by D. Bradley Welling, MD, PhD.
- Completed
- Registry status
- Phase 2
- Development phase
- 57
- Enrollment target
- 2
- Study locations
NCT02307916 is a Phase 2 study of Tympanic Membrane Perforation that has completed, run by D. Bradley Welling, MD, PhD. The registered enrollment target is 57 participants, below the 151-participant average among 3 other Tympanic Membrane Perforation trials with a reported enrollment target (62% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT02307916, a Phase 2 study of Tympanic Membrane Perforation, has completed, sponsored by D. Bradley Welling, MD, PhD.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 57 participants
- Enrollment target
- 2
- Study locations
Study Summary
A Phase II randomized trial will be initiated to evaluate closure of the perforated tympanic membrane as the primary measureable outcome. The goal is to determine the safety and efficacy of Fibroblast Growth Factor-2 (FGF-2) in the closure of chronic tympanic membrane perforations (TMP). If FGF-2 is topically applied for the treatment of chronic TMP in humans, it is hypothesized it will be safe, tolerable and effective for use as treatment for tympanic membrane perforation. A total of 60 subjects will be recruited.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG FGF-2
Study Locations (2)
Massachusetts
- Massachusetts Eye and Ear - Boston
Texas
- Wilford Hall, Lackland Airforce Base - Lackland City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2016-10 |
| Est. Completion | 2020-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02307916
The ClinicalTrials.gov registry entry for NCT02307916 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 151-participant average among 3 other Tympanic Membrane Perforation trials with a reported enrollment target (62% lower). The listed sponsor is D. Bradley Welling, MD, PhD, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tympanic Membrane Perforation appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02307916 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Texas.
Frequently Asked Questions
What is clinical trial NCT02307916 about?
NCT02307916 is a clinical study titled "Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations". A Phase II randomized trial will be initiated to evaluate closure of the perforated tympanic membrane as the primary measureable outcome. The goal is to determine the safety and efficacy of Fibroblast Growth Factor-2 (FGF-2) in the closure of chronic tympanic membrane perforations (TMP). If FGF-2 is...
What is the current status of trial NCT02307916?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 57 participants. The study started on 2016-10. Estimated completion is 2020-03.
What conditions does trial NCT02307916 study?
This clinical trial studies the following conditions: Tympanic Membrane Perforation.
What interventions are being tested in trial NCT02307916?
The interventions under investigation include: Placebo (OTHER), FGF-2 (DRUG).
Who is sponsoring clinical trial NCT02307916?
This trial is sponsored by D. Bradley Welling, MD, PhD, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02307916 being conducted?
This trial has 2 study locations across Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tympanic Membrane Perforation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.